Valneva grabs flu vax approval in Japan; China to supply encephalitis jab to India in U-turn decision;

> Valneva has won approval for its EB66-based prototype influenza vaccine in Japan. Report

> China has flip-flopped on an earlier decision, agreeing to provide India with additional supplies of Japanese encephalitis vaccine for expansion of the Indian government's immunization program. Report

> GeoVax ($GOVX) has appointed Immunovaccine veteran Randal Chase to its board of directors. Release

> Measles vaccination must be scaled up in Ebola-affected countries, the World Health Organization says. More

> Immunovaccine has started a Phase II clinical trial of its DPX-Survivac cancer vaccine in recurrent lymphoma. Release

> Medigene has kicked off a Phase I/II study with DC Vaccine in patients with acute myeloid leukaemia. Release

And Finally... GIV Mobile is partnering up with the International Aids Vaccine Initiative (IAVI) to help fund R&D. More

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.